Ran You
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
- Hepatology 12
- Hepatocellular Carcinoma Treatment and Prognosis 12
- Co-authors
- David B. Corry (6 shared papers)Farrah Kheradmand (6 shared papers)Li-zhen Song (2 shared papers)Xiaoyi Yuan (5 shared papers)Paul Porter (2 shared papers)Qingyu Xu (16 shared papers)Guowen Yin (11 shared papers)Matthew C. Madison (2 shared papers)
- Journals
- Journal of Clinical Investigation (3 papers)International Immunopharmacology (2 papers)Clinical and Experimental Pharmacology and Physiology (2 papers)Journal of Visualized Experiments (2 papers)Lara D. Veeken (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Ran You
52 papers receiving 1.1k citations
Ran You's Hit Papers
Peers
Comparison fields: 5 of 122
- Hepatology 78
- Cancer Research 146
- Physiology 241
- Pulmonary and Respiratory Medicine 191
- Immunology 124
Countries citing papers authored by Ran You
This map shows the geographic impact of Ran You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran You more than expected).
Fields of papers citing papers by Ran You
This network shows the impact of papers produced by Ran You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran You. The network helps show where Ran You may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran You, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Electronic cigarettes disrupt lung lipid homeostasis and innate immunity independent of nicotine Hit paper breakdown → | 2019 | 263 |
| 2 | 2016 | 143 | |
| 3 | 2015 | 88 | |
| 4 | 2014 | 63 | |
| 5 | 2015 | 62 | |
| 6 | 2012 | 59 | |
| 7 | 2012 | 38 | |
| 8 | 2019 | 31 | |
| 9 | 2023 | 29 | |
| 10 | 2010 | 22 | |
| 11 | 2019 | 22 | |
| 12 | 2019 | 20 | |
| 13 | 2021 | 19 | |
| 14 | 2022 | 17 | |
| 15 | 2023 | 17 | |
| 16 | 2016 | 15 | |
| 17 | 2023 | 15 | |
| 18 | 2016 | 15 | |
| 19 | 2023 | 13 | |
| 20 | 2018 | 13 |
About Ran You
Ran You is a scholar working on Hepatology, Molecular Biology, Pulmonary and Respiratory Medicine, Physiology and Immunology, having authored 59 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), Platelet Disorders and Treatments (3 papers), Peptidase Inhibition and Analysis (3 papers), Alzheimer's disease research and treatments (3 papers), T-cell and B-cell Immunology (3 papers) and Neuroinflammation and Neurodegeneration Mechanisms (3 papers). The work is most often cited by research in Hepatology (78 citations), Cancer Research (146 citations), Physiology (241 citations), Pulmonary and Respiratory Medicine (191 citations) and Immunology (124 citations). Ran You has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include David B. Corry, Farrah Kheradmand, Li-zhen Song, Xiaoyi Yuan, Paul Porter, Qingyu Xu, Guowen Yin, Matthew C. Madison, Bon‐Hee Gu and Nagireddy Putluri. Their work appears in journals such as Journal of Clinical Investigation, International Immunopharmacology, Clinical and Experimental Pharmacology and Physiology, Journal of Visualized Experiments and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.